Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $13.2500 (-4.95%) ($12.9100 - $13.2500) on Thu. Sep. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.64% (three month average) | RSI | 41 | Latest Price | $13.2500(-4.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -3.9% a day on average for past five trading days. | Weekly Trend | EDIT declines -4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(60%) IWC(57%) IWO(54%) IWM(53%) IBUY(51%) | Factors Impacting EDIT price | EDIT will decline at least -2.82% in a week (0% probabilities). VIXM(-17%) UUP(-14%) VXX(-9%) TBT(-9%) UNG(-0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.82% (StdDev 5.64%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $4.44(-66.49%) | Resistance Level | $15 | 5 Day Moving Average | $14.15(-6.36%) | 10 Day Moving Average | $14.77(-10.29%) | 20 Day Moving Average | $15(-11.67%) | To recent high | -31.4% | To recent low | 12.8% | Market Cap | $823m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |